loadpatents
name:-0.093054056167603
name:-0.047513961791992
name:-0.0039548873901367
Kishimoto; Tadamitsu Patent Filings

Kishimoto; Tadamitsu

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kishimoto; Tadamitsu.The latest application filed is for "novel therapeutic agent for gastrointestinal cancer and method for screening for the same".

Company Profile
6.47.26
  • Kishimoto; Tadamitsu - Osaka JP
  • Kishimoto; Tadamitsu - Tondabayashi N/A JP
  • KISHIMOTO; Tadamitsu - Tondabayashi-shi JP
  • - Tondabayashi JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Novel Therapeutic Agent For Gastrointestinal Cancer And Method For Screening For The Same
App 20220193113 - Kishimoto; Tadamitsu ;   et al.
2022-06-23
Therapeutic agent for a lung disease and/or method for screening for the same
Grant 11,279,931 - Kishimoto , et al. March 22, 2
2022-03-22
Novel Therapeutic Agent For A Lung Disease And/or Method For Screening For The Same
App 20200140862 - KISHIMOTO; Tadamitsu ;   et al.
2020-05-07
Therapeutic agent for a lung disease and/or method for screening for the same
Grant 10,550,387 - Kishimoto , et al. Fe
2020-02-04
Novel Therapeutic Agent For A Lung Disease And/or Method For Screening For The Same
App 20180195064 - KISHIMOTO; Tadamitsu ;   et al.
2018-07-12
Novel Therapeutic Agent for Septicemia, and a Method for Screening for Same
App 20180016576 - KISHIMOTO; Tadamitsu ;   et al.
2018-01-18
Mesothelioma therapeutic agent
Grant 8,802,092 - Nishimoto , et al. August 12, 2
2014-08-12
Preventive Agent For Vasculitis
App 20140079695 - Nishimoto; Norihiro ;   et al.
2014-03-20
Treatment of vasculitis with IL-6 antagonist
Grant 8,617,550 - Nishimoto , et al. December 31, 2
2013-12-31
Treatment of vasculitis with IL-6 antagonist
Grant 08617550 -
2013-12-31
Method for treating psoriasis by administering an antibody to interleukin-6 receptor
Grant 8,597,644 - Ito , et al. December 3, 2
2013-12-03
Method of treating psoriatic arthritis with an IL-6 receptor antibody
Grant 8,562,990 - Ito , et al. October 22, 2
2013-10-22
Vascularization Inhibitors
App 20130236889 - Kishimoto; Tadamitsu ;   et al.
2013-09-12
Inhibiting vascularization using antibodies to CXCR4 and SDF-1
Grant 8,119,126 - Kishimoto , et al. February 21, 2
2012-02-21
Preventive Or Therapeutic Agent For Psoriatic Arthritis Comprising Il-6 Antagonist As Active Ingredient
App 20110268734 - Ito; Hiroaki ;   et al.
2011-11-03
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
Grant 8,017,121 - Kishimoto , et al. September 13, 2
2011-09-13
Preventive or therapeutic agent for inflammatory bowel disease comprising IL-6 antagonist as an active ingredient
Grant 7,824,674 - Ito , et al. November 2, 2
2010-11-02
Mesothelioma therapeutic agent
App 20080274106 - Nishimoto; Norihiro ;   et al.
2008-11-06
Method of preparing heart muscle cells and method of searching for remedy for heart diseases
App 20080160553 - Kimura; Haruhide ;   et al.
2008-07-03
Preventive Or Therapeutic Agent For Psoriasis Comprising Il-6 Antagonist As Active Ingredient
App 20080124325 - Ito; Hiroaki ;   et al.
2008-05-29
Mouse CXC chemokine receptor
Grant 7,361,737 - Kishimoto , et al. April 22, 2
2008-04-22
Preventives or remedies for psoriasis containing as the active ingredient IL-6 antagonist
Grant 7,320,792 - Ito , et al. January 22, 2
2008-01-22
Screening method for a substance having hypoglycemic activity by using STAT-induced inhibitor of STAT function-1
Grant 7,247,424 - Kishimoto , et al. July 24, 2
2007-07-24
Mesothelioma therapeutic agent
App 20070134242 - Nishimoto; Norihiro ;   et al.
2007-06-14
Preventive agent for vasculitis
App 20070098714 - Nishimoto; Norihiro ;   et al.
2007-05-03
Pharmaceutical composition for treatment of diseases caused by IL-6 production
App 20070036785 - Kishimoto; Tadamitsu ;   et al.
2007-02-15
Novel mouse CXC chemokine receptor
App 20060211037 - Kishimoto; Tadamitsu ;   et al.
2006-09-21
Mouse CXC chemokine receptor
Grant 7,074,616 - Kishimoto , et al. July 11, 2
2006-07-11
Hydroxamic acid derivatives, the methods for preparation thereof and pharmaceutical compositions comprising thereof, as an active ingredient
App 20040214896 - Konno, Mitoshi ;   et al.
2004-10-28
Vascularization inhibitors
App 20040209837 - Kishimoto, Tadamitsu ;   et al.
2004-10-21
Hydroxamic acid derivatives, process for the production thereof and drug containing the same as the active ingredient
Grant 6,770,644 - Konno , et al. August 3, 2
2004-08-03
Method of treating inflammatory intestinal diseases containing as the ingredient IL-6 receptors antibodies
Grant 6,723,319 - Ito , et al. April 20, 2
2004-04-20
Preventive or therapeutic agent for inflammatory bowel disease comprising IL-6 antagonist as an active ingredient
App 20040071706 - Ito, Hiroaki ;   et al.
2004-04-15
Preventives or remedies for psoriasis containing as the active ingredient il-6 antagonist
App 20040028681 - Ito, Hiroaki ;   et al.
2004-02-12
Method of screening hypoglycemic substance by using stat inhibitory factor-1
App 20030186215 - Kishimoto, Tadamitsu ;   et al.
2003-10-02
Method of preparing heart muscle cells and method of searching for remedy for heart diseases
App 20030175847 - Kimura, Haruhide ;   et al.
2003-09-18
Fused thiophone derivatives and drugs containing the same as the active ingredient
Grant 6,555,555 - Konishi , et al. April 29, 2
2003-04-29
Fused thiophone derivatives and drugs containing the same as the active ingredient
App 20030073706 - Konishi, Mikio ;   et al.
2003-04-17
STAT function-regulatory protein
Grant 6,514,725 - Kishimoto , et al. February 4, 2
2003-02-04
Receptor protein for human B cell stimulatory factor-2
Grant 6,410,691 - Kishimoto June 25, 2
2002-06-25
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
App 20010001663 - Kishimoto, Tadamitsu ;   et al.
2001-05-24
Method of detecting solid cancer cells and tissue atypia and method of testing tissues for use in bone marrow transplantation and peripheral blood stem cell transplantation
Grant 6,225,051 - Sugiyama , et al. May 1, 2
2001-05-01
Receptor protein for human B cell stimulatory factor-2
Grant 5,990,282 - Kishimoto November 23, 1
1999-11-23
Chronic rheumatoid arthritis therapy containing IL-6 antagonist as effective component
Grant 5,888,510 - Kishimoto , et al. March 30, 1
1999-03-30
Monoclonal antibodies to GP130 protein
Grant 5,866,689 - Kishimoto , et al. February 2, 1
1999-02-02
Human acute phase response factor
Grant 5,844,082 - Kishimoto , et al. December 1, 1
1998-12-01
Nucleic acids encoding transcription factor APRF (acute phase response factor)
Grant 5,719,042 - Kishimoto , et al. February 17, 1
1998-02-17
Antibody to human interleukin-6 receptor
Grant 5,670,373 - Kishimoto September 23, 1
1997-09-23
Antibodies against the receptor protein for human B cell stimulatory factor-2
Grant 5,480,796 - Kishimoto January 2, 1
1996-01-02
Method to treat Kaposi's sarcoma
Grant 5,470,824 - Miles , et al. November 28, 1
1995-11-28
Receptor protein for human B cell stimulatory factor-2
Grant 5,171,840 - Kishimoto December 15, 1
1992-12-15
Human gp130 protein
Grant 5,132,403 - Kishimoto July 21, 1
1992-07-21
Method for treating thrombocytopenia
Grant 5,126,325 - Kishimoto , et al. June 30, 1
1992-06-30
Human cultured cell line
Grant 4,675,291 - Yamamura , et al. June 23, 1
1987-06-23
Human T cell lines and method of producing same
Grant 4,544,632 - Yamamura , et al. October 1, 1
1985-10-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed